Unilobar surgery for symptomatic epileptic spasms

Carmen Barba1, Roberto Mai2, Laura Grisotto3

  • 1Neuroscience Department Children's Hospital Anna Meyer-University of Florence Florence Italy.

Insights

Complete resection of the seizure onset zone and visible lesions improves outcomes for children with epileptic spasms. Early surgery is recommended to avoid longer epilepsy duration and unfavorable results.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neurosurgery

Background:

  • Epileptic spasms in children often stem from underlying structural abnormalities.
  • Understanding the pathophysiology and surgical outcomes is crucial for effective treatment.

Purpose of the Study:

  • To identify factors predicting favorable seizure outcomes after surgery for symptomatic epileptic spasms.
  • To enhance the understanding of the pathophysiology of this seizure type.

Main Methods:

  • Retrospective study of 80 children (6 months–15 years) with active epileptic spasms and >1 year follow-up.
  • Analysis included MRI findings, invasive recordings, and surgical resection extent.
  • Multivariate logistic regression was used to assess outcome predictors.

Main Results:

  • 96.3% of patients had MRI-detected structural abnormalities; 72.5% underwent unilobar resections.
  • 61.3% achieved favorable seizure control (Engel class I).
  • Complete resection of the seizure onset zone and visible lesions significantly predicted favorable outcomes (Engel class IA). Older age at surgery, indicating longer epilepsy duration, was associated with unfavorable outcomes.

Conclusions:

  • Focal cortical origin of spasms is supported by surgical outcomes and invasive recordings.
  • Surgery for spasms originating from discrete lesions should follow principles of focal epilepsy surgery, prioritizing unilobar, one-stage resections.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K